Detailed Narrative
Q3 FY25 Performance Overview and Export-Led Growth
Rossari Biotech reported a resilient Q3 FY25, with consolidated revenues increasing by 10.5% YoY to ₹512.7 crore. All business segments contributed to growth, with HPPC at ₹390 crore (+9.6% YoY), Textile Specialty Chemicals at ₹95 crore (+14.5% YoY), and AHN at ₹28 crore (+12% YoY). Exports were a significant driver, registering 21% YoY growth in Q3 and 28% over the nine months, with Q3 export revenue reaching ₹156 crore.
Margin Dynamics and Cost Structure
Gross margins improved by 137 basis points YoY, supported by a favorable product mix and operational efficiencies. However, EBITDA margins compressed to 12.6% (from 13.7% last year) due to higher expenses related to ongoing growth initiatives, capacity expansion, and investments in businesses in their growth phases, such as the institutional cleaning vertical. Employee costs increased with approximately 190 new hires YoY, with 120 in the institutional cleaning division alone.
Capacity Expansion and Ethoxylation Constraints
The company's CAPEX projects, including 30,000 tons of ethoxylation capacity expansion at Unitop's Dahej facility and HPPC expansion, are progressing well and are expected to be commissioned in a phased manner, with some in Q1 FY26. The total CAPEX spent is about ₹140 crore, projected to yield ₹550 crore in peak revenue (4x asset turn). However, a critical risk remains the uncertainty of Ethylene Oxide (EO) supply from Reliance, which could delay the full utilization of new capacities and impact revenue and margin growth in FY26.
Buzil Rossari (Rossari Professional) Business Update
The institutional cleaning business, Buzil Rossari (now Rossari Professional), achieved ₹200 crore in revenue in the first nine months, representing 50% YoY growth. Management aims for this business to reach over ₹250 crore by FY25 and ₹450-500 crore within two years. While currently operating at low EBITDA due to significant investments in expanding its offerings beyond pure chemicals to a complete hygiene solution, it is expected to start contributing positively to EBITDA once it reaches the ₹450-500 crore revenue mark.
Textile Business Recovery and Export Focus
The Textile Specialty Chemicals business showed a strong uptick, primarily driven by exports, which grew about 14% YoY in Q3. Domestic textile growth remains modest at 5-6%. The company is strategically focusing on high-margin finishing chemicals and expanding its export footprint in geographies like Egypt, Turkey, North Africa, and Bangladesh, with a long-term target of making Bangladesh a ₹100 crore geography. New offices are being set up in Vietnam, Thailand, Turkey, and UAE to support this export push.
Future Outlook and Strategic Initiatives
Rossari Biotech remains optimistic about sustained growth, driven by innovation, capacity enhancements, and global market expansion. New capacities are expected to start contributing to revenue from Q2 FY26, with full utilization anticipated in 3-3.5 years. The company is committed to leveraging strategic investments to unlock new opportunities and strengthen its market position, aiming for PAT growth to align with revenue growth in FY26, contingent on raw material availability.